Valneva SE VALN
NASDAQ VALN
$6.91 -0.15 (-2.10%)
As of: Sep 4, 2026 · 2:29 PM EDT

Valneva SE (VALN) Total Debt Growth (5y) (2025)

Analysis

Valneva SE (VALN) Total Debt Growth (5y) (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.77 Bn 130.92 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.51 Bn 77.52 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.20 Bn 53.06 Bn 52.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn -
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn
8 Royalty Pharma 28.40 Bn 27.56 Bn -
9 Insmed 27.44 Bn 26.28 Bn 358.27 Mn
10 Valneva SE 581.06 Mn 439.80 Mn 1.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 40.66%